MORAb-028 is a humanized IgG1 monoclonal antibody inhibitor targeting GD2. It exhibits potent antitumor activity by killing GD2-expressing target cells through complement-dependent cytotoxicity (CDC). In EL-4-luc xenograft mouse models, MORAb-028 significantly reduces tumor growth. This compound is applicable for melanoma cancer research.
Target-Kategorie:
Others
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten
